ASPHALION HIGHLIGHTS Q3 2023
A lot of things have happened at Asphalion during these past three months, and we have summarized
October 20, 2023
A lot of things have happened at Asphalion during these past three months, and we have summarized
TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.
A lot of things have happened during these past three months. We received an award from AEFI
ASPHALION is proud member of the consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting
The workshop will provide a platform for an exchange of views between industry, regulators and academia.
Have a look at this infographic that Extedo® and Asphalion have prepared with the summary updates in terms of publishing and eSubmission at a regional level, focused on INDs for US FDA
The meeting provided the opportunity to interact in person with all the consortium partners and establish the first collaborative activities to ensure timely delivery of the project milestones.
The second face-to-face RBDCOV meeting is taking place today at Palau Macaya in Barcelona! Our expert, Chris
Search or filter
Services
Memberships & Partnerships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
